In asymptomatic cases, if we do not institute prophylactic treatment, do all of the peripheral retinal lesions lead to retinal detachment? A MEDLINE literature search revealed a few natural ...
In TEASE-1, a placebo-controlled, double-masked, randomized 24-month study in patients with Stargardt disease, gildeuretinol ...
Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for geographic atrophy
Key findings include reduced lesion growth, retinal tissue preservation, and improved visual function, demonstrating ...
Ocugen (OCGN) announced positive preliminary efficacy and safety data from the Phase 1 dose-escalation portion of the Phase 1/2 OCU410 ArMaDa ...
This article focuses on the pathogenesis of retinal detachment as well as the specific lesions and risk factors that lead to retinal detachment. Treatment options for both symptomatic and ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window GA lesions, which form on the retina due to degeneration of pigment epithelium and photoreceptors, significantly impact ...
In a clinical trial, lampalizumab treatment (right) prevented retinal lesion growth and eye deterioration for 18 months in patients with dry age-related macular degeneration. Disclaimer ...
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback